Oxygen (placebo)

DRUG3 trials

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Bernardino Clavo, MD, PhD

Conditions

Acute Myocardial InfarctionChemotherapy Induced Peripheral Neuropathy (CIPN)NumbnessParesthesiaTingling

Phase 2

Sevoflurane In Acute Myocardial Infarction

CompletedNCT00971607

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sAcute Myocardial Infarction

Start: 2009-05-31End: 2013-12-31Updated: 2014-09-09

Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy

RecruitingNCT06706544

Bernardino Clavo, MD, PhDChemotherapy Induced Peripheral Neuropathy (CIPN), Numbness, Paresthesia +1

Start: 2025-02-07End: 2030-03-31Target: 42Updated: 2026-09-18

Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).

RecruitingNCT06799351

Bernardino Clavo, MD, PhDChemotherapy Induced Peripheral Neuropathy (CIPN), Numbness, Paresthesia +1

Start: 2025-02-07End: 2030-03-31Target: 42Updated: 2025-02-12

Related Papers

One-year outcome of the sevoflurane in acute myocardial infarction randomized trial.

2015-08-224 citations